Source comparison
Thymosin Alpha-1 Stacking Guide: Comparison Table
Different stacking combinations serve distinct research objectives. The following comparison evaluates common Thymosin Alpha-1 stacks based on mechanism, dosing complexity, and primary research applications. Thymosin Alpha-1 + BPC-157 + TB-500 Immune modulatio
This comparison does not assign a generated winner or score.
- Different stacking combinations serve distinct research objectives. The following comparison evaluates common Thymosin Alpha-1 stacks based on mechanism, dosing complexity, and primary research applications.
- Thymosin Alpha-1 + BPC-157 + TB-500
- Immune modulation + angiogenesis + tissue repair via actin binding
- TA1: 2x daily; BPC-157: 1–2x daily; TB-500: 2x weekly
- Tissue injury recovery, post-surgical healing, chronic inflammation models
- Minimal—distinct receptor pathways with complementary endpoints
- Gold standard for tissue repair research; well-documented synergy with low interference risk
- Thymosin Alpha-1 + Ipamorelin + CJC-1295
- Immune support + GH secretagogue (ghrelin receptor) + GHRH analog
- TA1: 2x daily; Ipamorelin: 3x daily; CJC-1295: 3x daily or 2x weekly (DAC version)
- Anabolic signaling studies, age-related immune decline, metabolic research
- None—immune and GH pathways operate independently
- Excellent for protocols requiring both immune and anabolic endpoints; timing complexity moderate
- Thymosin Alpha-1 + MOTS-C
- Immune differentiation + mitochondrial biogenesis and AMPK activation
- TA1: 2x daily; MOTS-C: 1x daily or 3x weekly depending on protocol
- Immune-metabolic interaction studies, aging research, endurance models
- Minimal—MOTS-C acts on metabolic gene expression, TA1 on adaptive immunity
- Emerging stack with strong mechanistic rationale; fewer published protocols than tissue repair stacks
- Thymosin Alpha-1 + Epithalon
- T-cell maturation + telomerase activation and pineal peptide regulation
- TA1: 2x daily; Epithalon: 1x daily for 10–20 day cycles
- Longevity research, immune senescence studies, circadian biology
- Low—Epithalon's primary effects are genomic and pineal, not immune receptor-mediated
- Theoretically sound but limited direct synergy evidence; works well in broader longevity stacks
- Thymosin Alpha-1 + Semax + Selank
- Immune enhancement + neurotropic (BDNF upregulation) + anxiolytic GABAergic modulation
- TA1: 2x daily; Semax: 2–3x daily intranasal; Selank: 2–3x daily intranasal
- Neuroimmune research, stress response studies, cognitive-immune interaction models
- Minimal—neurotropic peptides act on CNS pathways distinct from peripheral T-cell modulation
- Specialized stack for neuroimmunology research; administration routes differ (SC vs intranasal)
- Thymosin Alpha-1 Monotherapy
- T-cell differentiation, IL-2 and interferon upregulation
- 2x daily
- Isolated immune modulation studies, baseline immune response profiling
- N/A
- Simplest protocol; preferred when isolating immune variables without confounding tissue repair or metabolic signals